XML 64 R44.htm IDEA: XBRL DOCUMENT v3.8.0.1
Quarterly Financial Data (Unaudited) (Tables)
 12 Months Ended
Dec. 31, 2017
Quarterly Financial Information Disclosure [Abstract]  
Quarterly Financial Data (Unaudited)
The following table sets forth selected quarterly information (unaudited) (in thousands, except per share data):
 
Three Months Ended
 
March 31,
2017
 
June 30,
2017
 
September 30,
2017
 
December 31,
2017
Revenues
$
96,829

 
$
96,216

 
$
97,295

 
$
103,601

Gross profit
41,190

 
41,166

 
40,607

 
45,325

Loss from operations
(1,681
)
 
(2,056
)
 
(8,283
)
 
(1,831
)
Net loss
(1,541
)
 
(2,579
)
 
(8,894
)
 
(2,311
)
Net loss attributable to stockholders of NxStage Medical, Inc.
(1,189
)
 
(2,089
)
 
(8,445
)
 
(2,269
)
Net loss attributable to common stockholders
(1,189
)
 
(2,089
)
 
(8,926
)
 
(2,269
)
Net loss per share, basic and diluted
$
(0.02
)
 
$
(0.03
)
 
$
(0.14
)
 
$
(0.03
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended
 
March 31,
2016
 
June 30,
2016
 
September 30,
2016
 
December 31,
2016
Revenues
$
89,207

 
$
92,207

 
$
91,951

 
$
93,013

Gross profit
36,517

 
38,423

 
39,181

 
37,864

Loss from operations
(975
)
 
(1,180
)
 
24

 
(2,154
)
Net loss
(1,783
)
 
(2,225
)
 
(890
)
 
(2,419
)
Net loss attributable to stockholders of NxStage Medical, Inc.
(1,276
)
 
(1,732
)
 
(166
)
 
(1,597
)
Net loss attributable to common stockholders
(1,276
)
 
(1,732
)
 
(166
)
 
(1,597
)
Net loss per share, basic and diluted
$
(0.02
)
 
$
(0.03
)
 
$
(0.00
)
 
$
(0.02
)